• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学探讨桃仁-红花治疗糖尿病肾病的作用机制。

Using Network Pharmacology to Explore the Mechanism of Peach Kernel-Safflower in the Treatment of Diabetic Nephropathy.

机构信息

Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.

Heilongjiang Academy of Chinese Medical Sciences, Harbin 150036, China.

出版信息

Biomed Res Int. 2021 Feb 1;2021:6642584. doi: 10.1155/2021/6642584. eCollection 2021.

DOI:10.1155/2021/6642584
PMID:33604381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7870307/
Abstract

OBJECTIVE

The mechanism of peach kernel-safflower in treating diabetic nephropathy (DN) was investigated using network pharmacology.

METHODS

Network pharmacology methodology was applied to screen the effective compounds of peach kernel-safflower in the SymMap and TCMSP databases. Potential targets were then screened in the ETCM, SEA, and SymMap databases to construct a compound-target network. This was followed by screening of DN targets in OMIM, Gene, and GeneCards databases. The common targets of drugs and diseases were selected for analysis in the STRING database, and the results were imported into Cytoscape 3.8.0 to construct a protein-protein interaction network. Next, GO and KEGG enrichment analyses were performed. Finally, Schrödinger molecular docking verified the reliability of the results.

RESULTS

A total of 23 effective compounds and 794 potential targets resulted from our screening process. Quercetin and luteolin were identified as the main effective ingredients in peach kernel-safflower. Furthermore, five key targets (VEGFA, IL6, TNF, AKT1, and TP53), AGE-RAGE, fluid shear stress and atherosclerosis, IL-17, and HIF-1 signaling pathways may be involved in the treatment of DN using peach kernel-safflower.

CONCLUSIONS

This study embodies the complex network relationship of multicomponents, multitargets, and multipathways of peach kernel-safflower to treat DN and provides a basis for further research on its mechanism.

摘要

目的

采用网络药理学方法研究桃仁红花治疗糖尿病肾病(DN)的作用机制。

方法

在 SymMap 和 TCMSP 数据库中运用网络药理学方法筛选桃仁红花的有效化合物,然后在 ETCM、SEA 和 SymMap 数据库中筛选潜在靶点,构建化合物-靶点网络。接着在 OMIM、Gene 和 GeneCards 数据库中筛选 DN 靶点。在 STRING 数据库中对药物和疾病的共同靶点进行分析,并将结果导入 Cytoscape 3.8.0 构建蛋白-蛋白相互作用网络,然后进行 GO 和 KEGG 富集分析。最后,采用 Schrödinger 分子对接验证结果的可靠性。

结果

通过筛选,共得到 23 个有效化合物和 794 个潜在靶点。槲皮素和木樨草素被鉴定为桃仁红花的主要有效成分。此外,VEGFA、IL6、TNF、AKT1 和 TP53 等 5 个关键靶点(VEGFA、IL6、TNF、AKT1 和 TP53)、AGE-RAGE、流体切应力和动脉粥样硬化、IL-17 和 HIF-1 信号通路可能参与了桃仁红花治疗 DN 的作用。

结论

本研究体现了桃仁红花多成分、多靶点、多途径治疗 DN 的复杂网络关系,为进一步研究其作用机制提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/9459f70599da/BMRI2021-6642584.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/ea61fea73180/BMRI2021-6642584.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/7748f8567d5b/BMRI2021-6642584.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/f69f47f7ae77/BMRI2021-6642584.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/c8d7db420b0f/BMRI2021-6642584.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/b356a0177ecc/BMRI2021-6642584.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/67788b6fe477/BMRI2021-6642584.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/9459f70599da/BMRI2021-6642584.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/ea61fea73180/BMRI2021-6642584.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/7748f8567d5b/BMRI2021-6642584.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/f69f47f7ae77/BMRI2021-6642584.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/c8d7db420b0f/BMRI2021-6642584.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/b356a0177ecc/BMRI2021-6642584.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/67788b6fe477/BMRI2021-6642584.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa4/7870307/9459f70599da/BMRI2021-6642584.007.jpg

相似文献

1
Using Network Pharmacology to Explore the Mechanism of Peach Kernel-Safflower in the Treatment of Diabetic Nephropathy.基于网络药理学探讨桃仁-红花治疗糖尿病肾病的作用机制。
Biomed Res Int. 2021 Feb 1;2021:6642584. doi: 10.1155/2021/6642584. eCollection 2021.
2
Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Experiments.基于网络药理学和实验研究的黄芪-山茱萸治疗糖尿病肾病的作用机制。
Comb Chem High Throughput Screen. 2024;27(14):2078-2089. doi: 10.2174/0113862073241153231003094411.
3
Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.运用网络药理学和分子对接技术探索丹参治疗糖尿病肾病的作用机制
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20203520.
4
The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.基于网络药理学和分子对接技术的车前子治疗糖尿病肾病的机制研究。
Endocr Metab Immune Disord Drug Targets. 2024;24(3):363-379. doi: 10.2174/1871530323666230915100355.
5
The mechanism of peach kernel and safflower herb-pair for the treatment of liver fibrosis based on network pharmacology and molecular docking technology: A review.基于网络药理学和分子对接技术的桃仁红花药对治疗肝纤维化的机制研究:综述。
Medicine (Baltimore). 2023 Apr 21;102(16):e33593. doi: 10.1097/MD.0000000000033593.
6
Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接的麻黄草治疗肾病综合征的潜在分子机制。
Biomed Res Int. 2022 Jul 5;2022:9214589. doi: 10.1155/2022/9214589. eCollection 2022.
7
Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.基于网络药理学的六味地黄丸治疗帕金森病机制研究。
Biomed Res Int. 2021 Oct 28;2021:4490081. doi: 10.1155/2021/4490081. eCollection 2021.
8
Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.网络药理学分析结合实验验证探索五味子合剂治疗糖尿病肾病的作用机制。
J Ethnopharmacol. 2023 Feb 10;302(Pt A):115768. doi: 10.1016/j.jep.2022.115768. Epub 2022 Oct 22.
9
Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L.网络药理学探索揭示丹参和红花治疗心脑血管疾病的共同作用机制。
BMC Complement Med Ther. 2020 Nov 19;20(1):351. doi: 10.1186/s12906-020-03026-y.
10
Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis.基于网络药理学探讨三七治疗心肌纤维化的作用机制。
J Diabetes Res. 2022 Mar 25;2022:8895950. doi: 10.1155/2022/8895950. eCollection 2022.

引用本文的文献

1
Network pharmacology and experimental verification in vivo reveal the mechanism of Zhushao Granules against ulcerative colitis.网络药理学与体内实验验证揭示助芍颗粒抗溃疡性结肠炎的作用机制。
Biol Proced Online. 2025 Feb 14;27(1):7. doi: 10.1186/s12575-025-00268-3.
2
Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation.基于网络药理学和体内证据的五苓散抗高尿酸血症作用:改善氧化应激和抑制炎症。
Drug Des Devel Ther. 2023 Mar 4;17:675-690. doi: 10.2147/DDDT.S398625. eCollection 2023.
3
A Review of Traditional Chinese Medicine, Buyang Huanwu Decoction for the Treatment of Cerebral Small Vessel Disease.

本文引用的文献

1
AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy.AGE/RAGE 信号转导介导的内质网应激与非编码 RNA 治疗糖尿病肾病的前景。
Biomed Pharmacother. 2020 Nov;131:110655. doi: 10.1016/j.biopha.2020.110655. Epub 2020 Aug 24.
2
A review on anti-cancer properties of Quercetin in breast cancer.槲皮素在乳腺癌中的抗癌特性研究综述。
Life Sci. 2020 May 1;248:117463. doi: 10.1016/j.lfs.2020.117463. Epub 2020 Feb 22.
3
Luteolin Attenuates Diabetic Nephropathy through Suppressing Inflammatory Response and Oxidative Stress by Inhibiting STAT3 Pathway.
中医药治疗脑小血管病的研究进展:补阳还五汤的应用
Front Neurosci. 2022 Jun 29;16:942188. doi: 10.3389/fnins.2022.942188. eCollection 2022.
4
Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia.基于网络药理学分析及实验验证探究补芍调脂胶囊治疗高脂血症的作用机制
Sci Rep. 2022 Apr 28;12(1):6992. doi: 10.1038/s41598-022-11139-2.
5
Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension STAT3/HIF-1α/VEGF and FAK/AKT Signaling Pathways.丹参饮颗粒通过STAT3/HIF-1α/VEGF和FAK/AKT信号通路预防缺氧诱导的肺动脉高压。
Front Pharmacol. 2022 Mar 11;13:844400. doi: 10.3389/fphar.2022.844400. eCollection 2022.
木犀草素通过抑制信号转导和转录激活因子3(STAT3)通路抑制炎症反应和氧化应激来减轻糖尿病肾病。
Exp Clin Endocrinol Diabetes. 2021 Oct;129(10):729-739. doi: 10.1055/a-0998-7985. Epub 2020 Jan 2.
4
Interstitial HIF1A induces an estimated glomerular filtration rate decline through potentiating renal fibrosis in diabetic nephropathy.间质 HIF1A 通过增强糖尿病肾病中的肾纤维化导致估计肾小球滤过率下降。
Life Sci. 2020 Jan 15;241:117109. doi: 10.1016/j.lfs.2019.117109. Epub 2019 Nov 28.
5
Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.香草醛通过减少大鼠体内晚期糖基化终产物对糖尿病肾病的保护作用。
Life Sci. 2019 Dec 15;239:117088. doi: 10.1016/j.lfs.2019.117088. Epub 2019 Nov 21.
6
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.缺氧诱导因子-1α 是 SGLT2 抑制剂治疗糖尿病肾病的作用靶点。
Sci Rep. 2019 Oct 14;9(1):14754. doi: 10.1038/s41598-019-51343-1.
7
A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.糖尿病肾病中与肾纤维化相关的机制简述。
Adv Exp Med Biol. 2019;1165:49-79. doi: 10.1007/978-981-13-8871-2_4.
8
TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.TGF-β1-p53 协同作用调控肾脏的促纤维化基因表达谱:分子机制与临床意义。
FASEB J. 2019 Oct;33(10):10596-10606. doi: 10.1096/fj.201900943R. Epub 2019 Jul 6.
9
Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway.槲皮素通过 Hippo 通路抑制早期糖尿病肾病系膜细胞增殖。
Pharmacol Res. 2019 Aug;146:104320. doi: 10.1016/j.phrs.2019.104320. Epub 2019 Jun 17.
10
Up-regulation of hypoxia inducible Factor-1α in patients with diabetic nephropathy.糖尿病肾病患者中缺氧诱导因子-1α的上调
Niger J Clin Pract. 2019 Jun;22(6):750-753. doi: 10.4103/njcp.njcp_495_18.